Pharmacological management of renal colic in the older patient

Drugs and Aging

Volumn 24, Issue 11, 2007, Pages 891-900

  Welk, Blayne K ^a   Teichman, Joel M H ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

Author keywords

Alfuzosin, therapeutic use; Alpha adrenergic receptor antagonists, therapeutic use; Calcium channel antagonists, therapeutic use; Corticosteroids, therapeutic use; Desmopressin, therapeutic use; Doxazosin, therapeutic use; Elderly

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CODEINE; CORTICOSTEROID; DESMOPRESSIN; DICLOFENAC; DOXAZOSIN; IBUPROFEN; INDOMETACIN; KETOROLAC; NAPROXEN; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; TAMSULOSIN; TERAZOSIN;

AGITATION; AKATHISIA; ANXIETY; ARTICLE; BLOOD PRESSURE; BRONCHOSPASM; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONFUSION; CONGESTIVE HEART FAILURE; CONSTIPATION; DEPRESSION; DIZZINESS; DRUG TOLERABILITY; EDEMA; EJACULATION; FALLING; FLUSHING; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; GERIATRIC PATIENT; HEADACHE; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOMANIA; HYPOTENSION; INSOMNIA; KIDNEY COLIC; KIDNEY FAILURE; MONOTHERAPY; MYOCLONUS; NAUSEA; PEPTIC ULCER; PERIPHERAL EDEMA; PRIORITY JOURNAL; PRURITUS; RECOMMENDED DRUG DOSE; RESPIRATION DEPRESSION; RHINITIS; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; STROKE; TACHYCARDIA; TINNITUS; TREMOR; URETER STONE; URINE RETENTION; VOMITING; WEIGHT GAIN;

EID: 36049010175     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200724110-00002     Document Type: Article

References (83)

1. Sierakowski R, Finlayson B, Landes RR, et al. The frequency of urolithiasis in hospital discharge diagnoses in the United States. Invest Urol 1978; 15: 438-41
2. Evan AP, Coe FL, Lingeman JE, et al. Insights on the pathology of kidney stone formation. Urol Res 2005; 33: 383-9
3. Pak CY. Medical management of urinary stone disease. Nephron Clin Pract 2004; 98: c49-53
4. Miller OF, Kane CJ. Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol 1999; 162: 688-90
5. Manthey DE, Teichman J. Nephrolithiasis. Emerg Med Clin North Am 2001; 19: 33-54
6. Teichman JMH. Acute renal colic from ureteral calculus. New Engl J Med 2004; 350: 684-93
7. Vieweg J, Teh C, Freed K, et al. Unenhanced helical computerized tomography for the evaluation of patients with acute flank pain. J Urol 1998; 160: 679-84
8. Smith RC, Verga M, McCarthy S, et al. Diagnosis of acute flank pain: value of unenhanced helical CT. Am J Roentgenol 1996; 166: 97-101
9. Vaughan Jr ED, Gillenwater JY. Recovery following complete chronic unilateral ureteral occlusion: functional, radiographic and pathologic alterations. J Urol 1971; 106: 27-35
10. Andren-Sandberg A. Permanent impairment of renal function demonstrated by renographic follow-up in ureterolithiasis. Scand J Urol Nephrol 1983; 74: 81-4
11. Kelleher JP, Plail RO, Dave SM, et al. Sequential renography in acute urinary tract obstruction due to stone disease. Br J Urol 1991; 67: 125-8
12. Sowter SJ, Tolley DA. The management of ureteric colic. Curr Opin Urol 2006; 16: 71-6
13. Field TS, Gurwitz JH, Glynn RJ, et al. The renal effects of nonsteroidal anti-inflammatory drugs in older people: findings from the established populations for epidemiologic studies of the elderly. J Am Geriatr Soc 1999; 47: 507-11
14. Bell GM, Schnitzer TJ. COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of pain in the elderly. Clin Geriatr Med 2001; 17: 489-502
15. Zabihi N, Teichman JMH. Dealing with the pain of renal colic. Lancet 2001; 358: 437-8
16. Holdgate A, Pollock T. Systematic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic. BMJ 2004; 328: 1401
17. Todesco S. Special considerations in the use of NSAIDs in the elderly. Eur J Rheumatol Inflamm 1994; 14: 7-13
18. Nikolaus T, Zeyfang A. Pharmacological treatments for persistent non-malignant pain in older persons. Drugs Aging 2004; 21: 19-41
19. Todesco S. Special considerations in the use of NSAIDs in the elderly. Eur J Rheumatol Inflamm 1994; 14: 7-13
20. Bird HA. When are NSAIDs appropriate in osteoarthritis? Drugs Aging 1998; 12: 87-95
21. Whelton A. Clinical implications of nonopioid analgesia for relief of mild-to-moderate pain in patients with or at risk for cardiovascular disease. Am J Cardiol 2006; 97: 3-9
22. Barkin RL, Barkin SJ, Barkin DS. Perception, assessment, treatment and management of pain in the elderly. Clin Geriatr Med 2005; 21: 465-90
23. Whelton A. Renal aspects of treatment with conventional non-steroidal anti-inflammatory drugs versus cyclooxygenase-2 specific inhibitors. Am J Med 2001; 110 Suppl. 3A: 33s-42s
24. Nissen I, Birke H, Olson JB, et al. Treatment of ureteric colic: intravenous versus rectal administration of indomethacin. Br J Urol 1990; 65: 576-9
25. Safdar B, Degrutis LC, Landry K, et al. Intravenous morphine plus ketorolac is superior to either drug alone for treatment of acute renal colic. Ann Emerg Med 2006; 48: 173-81
26. Larkin GL, Peacock WF, Pearl SM, et al. Efficacy of ketorolac tromethamine versus meperidine in the ED treatment of acute renal colic. Am J Emerg Med 1999; 17: 6-10
27. Reinhart DI. Minimizing the adverse effects of ketorolac. Drug Saf 2000; 22: 487-97
28. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving non-steroidal anti-inflammatory drugs. Ann Intern Med 1995; 123: 241-9
29. Davenport K, Timoney AG, Keeley FX. Conventional and alternative methods for providing analgesia in renal colic. BJU Int 2005; 95: 297-300
30. Committee on Safety of Medicines. Relative safety of oral non-aspirin NSAIDs. Curr Probl Pharmacovig 1994; 20: 9-11
31. Smally AJ. Analgesia in renal colic. Ann Emerg Med 1997; 29: 297-9
32. Kaiko RF, Benzinger DP, Fitzmartin RD, et al. Pharmacokinetic- pharmacodynamic relationships of controlled-release oxycodone. Clin Pharmacol Ther 1996; 59: 52-61
33. Weiner DK, Hanlon JT. Pain in nursing home residents: management strategies. Drugs Aging 2001; 18: 13-29
34. Gloth FM. Pain management in older adults: prevention and treatment. J Am Geriatr Soc 2001 Feb; 49: 188-99
35. Lennon GM, Bourke J, Ryan PC, et al. Pharmacological options for the treatment of acute ureteric colic. Br J Urol 1993; 71: 401-7
36. Chutka DS, Takahashi PY, Hoel RW. Inappropriate medications for elderly patients. Mayo Clin Proc 2004; 79: 122-39
37. American Geriatrics Society. The management of chronic pain in older persons: AGS panel on chronic pain in older persons. J Am Geriatr Soc 1998; 46: 635-51
38. Duggleby W, Lander J. Cognitive status and postoperative pain: older adults. J Pain Symptom Manage 1994; 9: 19-27
39. Davies G, Kingswood C, Street M. Pharmacokinetics of opioids in renal dysfunction. Clin Pharmacokinet 1996; 31: 410-22
40. Sarhill N, Walsh D, Nelson KA. Hydromorphone: pharmacology and clinical applications in cancer patients. Support Care Cancer 2001; 9: 84-96
41. Lee MA, Leng ME, Tiernan EJ. Retrospective study of the use of hydromorphone in palliative care patients with normal and abnormal urea and creatinine. Palliat Med 2001; 15: 26-34
42. El-Sherif AE, Salem M, Yahia H, et al. Treatment of renal colic by desmopressin intranasal spray and diclofenac sodium. J Urol 1995; 153: 1395-8
43. Marumo F, Edelman IS. Effect of Ca++ and prostaglandin E1 on vasopressin activation of renal adenyl cyclase. J Clin Invest 1971; 50: 1613-20
44. Moro U, De Stefani S, Crisci A, et al. Evaluation of the effects of desmopressin in acute ureteral obstruction. Urol Int 1999; 62: 8-11
45. Bond L, Bevan D. Myocardial infarction in a patient with hemophilia treated with DDAVP. N Engl Med J 1988 Jan 14; 318 (2): 121
46. sanofi-aventis. Product information: desmopressin acetate, April 2006 [online]. Available from URL: http://products.sanofi-aventis.us/DDAVPTablet/ DDAVP_Tablets.pdf [Accessed 2007 Sep 19]
47. Lopes T, Dias JS, Marcelino J, et al. An assessment of the clinical efficacy of intranasal desmopressin spray in the treatment of renal colic. BJU Int 2001; 87: 322-5
48. Constantinides C, Kapralos V, Manousakas T, et al. Management of renal colic with intranasal desmopressin spray. Acta Urol Belg 1998; 66: 1-3
49. Odeh M, Oliven A. Coma and seizures due to severe hyponatremia and water intoxication in an adult with intranasal desmopressin therapy for nocturnal enuresis. J Clin Pharmacol 2001; 41: 582
50. Dunn CJ, Matheson A, Faulds DM. Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms. Drugs Aging 2002; 19: 135-61
51. Hollingsworth JM, Rogers MA, Kaufman SR, et al. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 2006; 368: 1171-9
52. Dellabella M, Milanese G, Muzzonigro G. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 2003; 170: 2202-5
53. Dellabella M, Milanese G, Muzzonigro G. Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol 2005; 174: 167-72
54. Troxel SA, Jones AW, Magliola L, et al. Physiologic effect of nifedipine and tamsulosin on contractility of distal ureter. J Endourol 2006; 20: 565-8
55. Dunn CJ, Matheson A, Faulds DM. Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms. Drugs Aging 2002; 19: 135-61
56. Mann RD, Biswas P, Freemantle S, et al. The pharmacovigilance of tamsulosin: event data on 12,484 patients. BJU Int 2000; 85: 446-50
57. Michel MC, Mehlburger L, Bressel HU, et al. Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: does comorbidity alter tolerability? J Urol 1998; 160: 784-91
58. Chapple CR, Wyndaele JJ, Nordling J, et al. Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist: a meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group. Eur Urol 1996; 29: 155-67
59. Milani S, Djavan B. Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: latest update on alpha-adrenoceptor antagonists. BJU Int 2005; 95 Suppl. 4: 29-36
60. Lepor H. The evolution of alpha-blockers for the treatment of benign prostatic hyperplasia. Rev Urol 2006; 8 Suppl. 4: S3-9
61. Yilmaz E, Batislam E, Basar MM, et al. The comparison and efficacy of 3 different alpha 1-adrenergic blockers for distal ureteral stones. J Urol 2005; 173: 2010-2
62. Andersson KE, Foreman A. Effects of calcium channel blockers on urinary tract smooth muscle. Acta Pharmacol Toxicol 1986; 58: 193-200
63. Davenport K, Timoney AG, Keeley FX. A comparative in vitro study to determine the beneficial effect of calcium-channel and alpha(1)-adrenoceptor antagonism on human ureteric activity. BJU Int 2006; 98: 651-5
64. Opie LH. Calcium channel antagonists in the treatment of coronary artery disease: fundamental pharmacological properties relevant to clinical use. Prog Cardiovasc Dis 1996; 38: 273-90
65. Abernethy DR, Schwartz JB. Calcium-antagonist drugs. N Engl J Med 1999; 341: 1447-57
66. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995; 274: 620-5
67. Michels KB, Rosner BA, Manson JE, et al. Prospective study of calcium channel blocker use, cardiovascular disease, and total mortality among hypertensive women: the Nurses' Health Study. Circulation 1998; 97: 1540-8
68. Kizer JR, Kimmel SE. Epidemiologic review of the calcium channel blocker drugs: an up-to-date perspective on the proposed hazards. Arch Intern Med 2001; 161: 1145-58
69. Caravati EM, Runge JW, Bossart PJ. Nifedipine for the relief of renal colic: a double-blind, placebo-controlled clinical trial. Ann Emerg Med 1989; 18: 352-4
70. Borghi L, Meschi T, Amato F, et al. Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, double-blind, placebo controlled study. J Urol 1994; 152: 1095-8
71. Porpiglia F, Destefanis P, Fontana D. Effectiveness of nifedipine and delazacort in the management of distal ureter stones. Urology 2000; 56: 579-83
72. Chen CC, Sun YT, Chen JJ, et al. TNF-alpha-induced cyclooxygenase-2 expression in human lung epithelial cells: involvement of the phospholipase C-gamma 2, protein kinase C-alpha, tyrosine kinase, NF-kappa B-inducing kinase, and I-kappa B kinase 1/2 pathway. J Immunol 2000; 165: 2719-28
73. Adcock IM, Ito K, Barnes PJ. Glucocorticoids: effects on gene transcription. Proc Am Thorac Soc 2004; 1: 247-54
74. Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 2004; 141: 764-70
75. White KP, Driscoll MS, Rothe MJ, et al. Severe adverse cardiovascular effects of pulse steroid therapy: is continuous cardiac monitoring necessary? J Am Acad Dermatol 1994; 30: 768-73
76. Piper JM, Ray WA, Daugherty JR, et al. Glucocorticoid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991; 114: 735-40
77. Saruta T, Suzuki H, Handa M, et al. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome. J Clin Endocrinol Metab 1986; 62: 275-9
78. Taylor LJ. Multifocal avascular necrosis after short-term high dose steroid therapy. J Bone Joint Surg Br 1984; 66: 431-3
79. Kershner P, Wang-Cheng R. Psychiatric side effects of steroid therapy. Psychosomatics 1989; 30: 135-9
80. Porpiglia F, Vaccino D, Billia M, et al. Corticosteroids and tamsulosin in the medical expulsive therapy for symptomatic distal ureter stones: single drug or association? Eur Urol 2006; 50: 339-44
81. Dellabella M, Milanese G, Muzzonigro G. Medical-expulsive therapy for distal ureterolithiasis: randomized prospective study on role of corticosteroids used in combination with tamsulosin-simplified treatment regimen and health-related quality of life. Urology 2005; 66: 712-5
82. Porpiglia F, Ghignone G, Fiori C, et al. Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 2004; 172: 568-71
83. Taghavi R, Barabi MR, Tavakoli K, et al. Survey of the effect of tamsulosin and nifedipine on facilitating juxtavesical ureteral stone passage [abstract]. J Endourol 2005; 19 Suppl. 1: A9